Trisk Bio
5 employees on LinkedIn · 2 known investors
Trisk Bio develops scalable preclinical manufacturing processes for AAV (adeno-associated virus) gene therapies, offering bespoke production, purification, and process optimization services. It serves gene therapy developers and preclinical research teams in the biotech industry.
Investors · 2
In the news
Frequently asked questions
- What does Trisk Bio do?
- Trisk Bio develops scalable preclinical manufacturing processes for AAV (adeno-associated virus) gene therapies, offering bespoke production, purification, and process optimization services. It serves gene therapy developers and preclinical research teams in the biotech industry.
- Who are Trisk Bio's investors?
- Trisk Bio's investors include Good Friends, Matrix.